Safinamide in Parkinson's disease-Settle Open Label Extension Study
Research type
Research Study
Full title
Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson’s Disease Patients
IRAS ID
33197
Contact name
David Burn
Sponsor organisation
Sponsor UK Contact: Quintiles.ltd
Eudract number
2008-005492-94
ISRCTN Number
N/A
Clinicaltrials.gov Identifier
N/A
Research summary
The 28850 trial is an open label extension to the current active 27919 Parkinson's Disease trial (PD). This is a 3-year, single arm, open-label, multi-center, multinational trial of Safinamide (50-100 mg/day) in subjects which have completed the previous safinamide clinical study (27919) and who meet all inclusion/exclusion criteria.
REC name
North East - Newcastle & North Tyneside 2 Research Ethics Committee
REC reference
09/H0907/72
Date of REC Opinion
9 Dec 2009
REC opinion
Further Information Favourable Opinion